EGFL7 Activators
EGFL7 activators constitute a diverse array of chemicals that play a pivotal role in augmenting the functional activity of EGFL7 through the initiation of specific signaling pathways and biological processes. These pathways, including PI3K/Akt, JAK2/STAT5, cAMP/PKA, JNK, and PKC/NF-κB, orchestrate a cascade of events culminating in the direct phosphorylation and activation of EGFL7, thereby enhancing its functional activity. Chemicals such as VEGF, Erythropoietin, and Insulin exert their EGFL7-activating effects by initiating the PI3K/Akt and JAK2/STAT5 pathways. Activation of these pathways leads to the direct phosphorylation and subsequent activation of EGFL7, highlighting the intricate interplay between growth factors and EGFL7 regulation. Furthermore, Anisomycin and Sodium orthovanadate activate the JNK and MAPK pathways, resulting in the direct phosphorylation and activation of EGFL7. This diverse set of activators underscores the versatility of signaling pathways involved in EGFL7 regulation.
Bradykinin, Forskolin, IBMX, Epinephrine, and Isoproterenol contribute to the enhancement of EGFL7 activity through the manipulation of cAMP levels. By modulating cAMP levels, these chemicals activate PKA, which, in turn, phosphorylates EGFL7. This intricate interplay between cAMP-mediated signaling and EGFL7 activation further expands the repertoire of pathways involved in the regulation of this crucial angiogenesis modulator. In summary, EGFL7 activators employ a range of pathways, including PI3K/Akt, JAK2/STAT5, cAMP/PKA, JNK, and PKC/NF-κB, to facilitate the direct phosphorylation and activation of EGFL7. The specific targeting of these pathways by various chemicals highlights the complexity and adaptability of the cellular regulatory network governing EGFL7 function, providing valuable insights into potential strategies for modulating angiogenesis and related processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin binds to the insulin receptor, leading to the activation of the PI3K/Akt pathway. This can directly phosphorylate and activate EGFL7, leading to its increased functional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is an activator of the JNK pathway. Activation of JNK can lead to the phosphorylation and activation of EGFL7, leading to its increased functional activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a tyrosine phosphatase inhibitor. By inhibiting tyrosine phosphatases, it can increase the phosphorylation and activation of proteins in the JNK and MAPK pathways. Activation of these pathways can directly phosphorylate and activate EGFL7, leading to its increased functional activity. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates its receptor, B2R. Activation of B2R can stimulate the phospholipase C pathway, which can directly phosphorylate and activate EGFL7, leading to its increased functional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, which can increase cAMP levels in cells. Increased cAMP can stimulate Protein Kinase A (PKA), which can directly phosphorylate and activate EGFL7, leading to its increased functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a phosphodiesterase inhibitor. By inhibiting phosphodiesterases, IBMX increases the level of cAMP in cells, which can activate PKA. Activated PKA can directly phosphorylate and activate EGFL7, leading to its increased functional activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is an adrenergic receptor agonist. Activation of adrenergic receptors can increase cAMP levels, leading to activation of PKA. PKA can directly phosphorylate and activate EGFL7, leading to increased functional activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta-adrenergic agonist. Activation of beta-adrenergic receptors can increase cAMP levels, leading to PKA activation. PKA can directly phosphorylate and activate EGFL7, leading to increased functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC). Activation of PKC can lead to the phosphorylation and activation of EGFL7, leading to its increased functional activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of IκBα phosphorylation, which leads to the activation of NF-κB. Activated NF-κB can increase the phosphorylation and activation of EGFL7, leading to its increased functional activity. | ||||||